Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Composés actifs
Mécanisme d'action
Preuves cliniques
Oral administration of Melon GliSODin (500.4 mg/day) tended to be associated with a larger improvement in subjective symptoms and motor function in women aged 50-80 years [PMID:35628874]
Supplementation with GliSODin was effective in controlling the thickness of the carotid artery intima and media layers in active adults with cardiovascular risk factors [PMID:17441415]
In international level rowers, 6-week supplementation with GliSODin resulted in significantly lower levels of creatine kinase (CK) and interleukin-6 (IL-6) [PMID:36290341]
In a mouse model, Melon GliSODin suppressed liver fibrosis and fat accumulation by reducing fat synthesis and activating antioxidative mechanisms [PMID:31374969]
In rats, GliSODin demonstrated a protective effect against azoxymethane-induced oxidative stress and carcinogenesis in the colon [PMID:34916376]
Posologie et administration
Synthèse des preuves
Sources PubMed
- 1.PMID: 34916376 (2021) — Protective role of a melon superoxide dismutase combined with gliadin (GliSODin) on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. · Journal of cancer research and therapeutics
- 2.PMID: 28825637 (2017) — Superoxide Dismutases in Pancreatic Cancer. · Antioxidants (Basel, Switzerland)
- 3.PMID: 35628874 (2022) — Clinical Efficacy of Melon GliSODin® for the Treatment of Aging-Related Dysfunction in Motor Organs-A Double Blind, Randomized Placebo-Controlled Study. · Journal of clinical medicine
- 4.PMID: 31374969 (2019) — Melon GliSODin® Prevents Diet-Induced NASH Onset by Reducing Fat Synthesis and Improving Liver Function. · Nutrients
- 5.PMID: 15742357